Fuda Xie

Fuda Xie

Auto-generated profile, based on publicly available information

Fuda Xie

Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2023 in Cancers
Verified
Journal Article
Open access
PDF file
WSWing Sum Shin
Wing Sum Shin
FXFuda Xie
Fuda Xie
BCBonan Chen
Bonan Chen
PYPeiyao Yu
Peiyao Yu
JYJun Yu
Jun Yu
Wei KangWei Kang
Wei Kang
Despite the decline in incidence and mortality rates, gastric cancer (GC) is the fifth leading cause of cancer deaths worldwide. The incidence and mortality of GC are exceptionally high in Asia due to high H. pylori infection, dietary habits, smoking behaviors, and heavy alcohol consumption. In Asia, males are more susceptible to developing GC than females. Variations in H. pylori strains and prevalence rates may contribute to the differences in incidence and mortality rates across Asian countries. Large-scale H. pylori eradication was one of the effective ways to reduce GC incidences. Treatment methods and clinical trials have evolved, but the 5-year survival rate of advanced GC is still low. Efforts should be put towards large-scale screening and early diagnosis, precision medicine, and deep mechanism studies on the interplay of GC cells and microenvironments for dealing with peritoneal metastasis and prolonging patients’ survival.

24 July 2024 in Cancer Research
Verified
Journal Article
Open access
PDF file
XLXiaoli Liu
Xiaoli Liu
BCBonan Chen
Bonan Chen
FXFuda Xie
Fuda Xie
KWKit Yee. Wong
Kit Yee. Wong
ACAlvin Ho-Kwan Cheung
Alvin Ho-Kwan Cheung
Wei KangWei Kang
Wei Kang
The Hippo–YAP1 pathway is an evolutionally conserved signaling cascade that controls organ size and tissue regeneration. Dysregulation of Hippo–YAP1 signaling promotes initiation and progression of several types of cancer, including gastric cancer. As the Hippo–YAP1 pathway regulates expression of thousands of genes, it is important to establish which target genes contribute to the oncogenic program driven by YAP1 to identify strategies to circumvent it. In this study, we identified a vital role of forkhead box protein 4 (FOXP4) in YAP1-driven gastric carcinogenesis by maintaining stemness and promoting peritoneal metastasis. Loss of FOXP4 impaired gastric cancer spheroid formation and reduced stemness marker expression, whereas FOXP4 upregulation potentiated cancer cell stemness. RNA sequencing analysis revealed SOX12 as a downstream target of FOXP4, and functional studies established that SOX12 supports stemness in YAP1-induced carcinogenesis. A small-molecule screen identified 42-(2-tetrazolyl) rapamycin as a FOXP4 inhibitor, and targeting FOXP4 suppressed gastric cancer tumor growth and enhanced the efficacy of 5-fluorouracil chemotherapy in vivo. Collectively, these findings revealed that FOXP4 upregulation by YAP1 in gastric cancer regulates stemness and tumorigenesis by upregulating SOX12. Targeting the YAP1–FOXP4–SOX12 axis represents a potential therapeutic strategy for gastric cancer. Significance: Hippo–YAP1 signaling maintains stemness in gastric cancer by upregulating FOXP4, identifying FOXP4 as a stemness biomarker and therapeutic target that could help improve patient outcomes.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
FXFuda Xie
Fuda Xie
MXMingxiang Xie
Mingxiang Xie
YYYibing Yang
Yibing Yang
MZMiaomiao Zhang
Miaomiao Zhang
XXXiaojie Xu
Xiaojie Xu
JGJiangyong Gu
Jiangyong Gu
Reduning Injection (RDNI) is a traditional Chinese medicine formula indicated for the treatment of inflammatory diseases. However, the molecular mechanism of RDNI is unclear. The information of RDNI ingredients was collected from previous studies. Targets of them were obtained by data mining and molecular docking. The information of targets and related pathways was collected in UniProt and KEGG. Networks were constructed and analyzed by Cytoscape to identify key compounds, targets, and pathways. Data mining and molecular docking identified 11 compounds, 84 targets, and 201 pathways that are related to the anti‐inflammatory activity of RDNI. Network analysis identified two key compounds (caffeic acid and ferulic acid), five key targets (Bcl‐2, eNOS, PTGS2, PPARA, and MMPs), and four key pathways (estrogen signaling pathway, PI3K‐AKT signaling pathway, cGMP‐PKG signaling pathway, and calcium signaling pathway) which would play critical roles in the treatment of inflammatory diseases by RDNI. The cross‐talks among pathways provided a deeper understanding of anti‐inflammatory effect of RDNI. RDNI is capable of regulating multiple biological processes and treating inflammation at a systems level. Network pharmacology is a practical approach to explore the therapeutic mechanism of TCM for complex disease.

15 October 2023 in Cancers
Verified
Journal Article
Open access
PDF file
WSWing Sum Shin
Wing Sum Shin
FXFuda Xie
Fuda Xie
BCBonan Chen
Bonan Chen
JYJun Yu
Jun Yu
KLKwok Wai Lo
Kwok Wai Lo
Wei KangWei Kang
Wei Kang
While previous research has primarily focused on the impact of H. pylori and Epstein-Barr virus (EBV), emerging evidence suggests that other microbial influences, including viral and fungal infections, may also contribute to gastric cancer (GC) development. The intricate interactions between these microbes and the host’s immune response provide a more comprehensive understanding of gastric cancer pathogenesis, diagnosis, and treatment. The review highlights the roles of established players such as H. pylori and EBV and the potential impacts of gut bacteria, mainly Lactobacillus, Streptococcus, hepatitis B virus, hepatitis C virus, and fungi such as Candida albicans. Advanced sequencing technologies offer unprecedented insights into the complexities of the gastric microbiome, from microbial diversity to potential diagnostic applications. Furthermore, the review highlights the potential for advanced GC diagnosis and therapies through a better understanding of the gut microbiome.

1 November 2021 in Industrial Crops and Products
Verified
Journal Article
Closed access
BLBai-Lin Li
Bai-Lin Li
JXJin-Dan Xie
Jin-Dan Xie
FXFu-Da Xie
Fu-Da Xie
HLHai-Yan Li
Hai-Yan Li
JHJuan-Juan Hu
Juan-Juan Hu
JWJie-wei Wu
Jie-wei Wu

20 July 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MXMingxiang Xie
Mingxiang Xie
MZMiaomiao Zhang
Miaomiao Zhang
YQYuanyuan Qiao
Yuanyuan Qiao
YYYibing Yang
Yibing Yang
FXFuda Xie
Fuda Xie
JGJiangyong Gu
Jiangyong Gu